288 related articles for article (PubMed ID: 33145269)
1. Identification of molecular features correlating with tumor immunity in gastric cancer by multi-omics data analysis.
He Y; Wang X
Ann Transl Med; 2020 Sep; 8(17):1050. PubMed ID: 33145269
[TBL] [Abstract][Full Text] [Related]
2. Identification of tumor mutation burden-associated molecular and clinical features in cancer by analyzing multi-omics data.
Li M; Gao X; Wang X
Front Immunol; 2023; 14():1090838. PubMed ID: 36911742
[TBL] [Abstract][Full Text] [Related]
3. Identifying tumor immunity-associated molecular features in liver hepatocellular carcinoma by multi-omics analysis.
Shen Q; He Y; Qian J; Wang X
Front Mol Biosci; 2022; 9():960457. PubMed ID: 36339710
[No Abstract] [Full Text] [Related]
4. Multi-OMICs data analysis identifies molecular features correlating with tumor immunity in colon cancer.
Elsayed I; Elsayed N; Feng Q; Sheahan K; Moran B; Wang X
Cancer Biomark; 2022; 33(2):261-271. PubMed ID: 35213358
[TBL] [Abstract][Full Text] [Related]
5.
Li L; Li M; Jiang Z; Wang X
Cells; 2019 Jul; 8(7):. PubMed ID: 31277418
[TBL] [Abstract][Full Text] [Related]
6. Identifying biomarkers associated with immunotherapy response in melanoma by multi-omics analysis.
He Y; Wang X
Comput Biol Med; 2023 Dec; 167():107591. PubMed ID: 37875043
[TBL] [Abstract][Full Text] [Related]
7.
Li M; Ma Y; Zhong Y; Liu Q; Chen C; Qiang L; Wang X
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33037113
[TBL] [Abstract][Full Text] [Related]
8. Immunogenomics Analysis Reveals that TP53 Mutations Inhibit Tumor Immunity in Gastric Cancer.
Jiang Z; Liu Z; Li M; Chen C; Wang X
Transl Oncol; 2018 Oct; 11(5):1171-1187. PubMed ID: 30059832
[TBL] [Abstract][Full Text] [Related]
9. Identification of gastric cancer subtypes based on pathway clustering.
Li L; Wang X
NPJ Precis Oncol; 2021 Jun; 5(1):46. PubMed ID: 34079012
[TBL] [Abstract][Full Text] [Related]
10. A Signature-Based Classification of Gastric Cancer That Stratifies Tumor Immunity and Predicts Responses to PD-1 Inhibitors.
Li S; Gao J; Xu Q; Zhang X; Huang M; Dai X; Huang K; Liu L
Front Immunol; 2021; 12():693314. PubMed ID: 34177954
[TBL] [Abstract][Full Text] [Related]
11. Molecular classification of human papillomavirus-positive cervical cancers based on immune signature enrichment.
Song G; Luo J; Zou S; Lou F; Zhang T; Zhu X; Yang J; Wang X
Front Public Health; 2022; 10():979933. PubMed ID: 36203656
[TBL] [Abstract][Full Text] [Related]
12. Increased glycolysis correlates with elevated immune activity in tumor immune microenvironment.
Jiang Z; Liu Z; Li M; Chen C; Wang X
EBioMedicine; 2019 Apr; 42():431-442. PubMed ID: 30935888
[TBL] [Abstract][Full Text] [Related]
13. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
14. HIF1A expression correlates with increased tumor immune and stromal signatures and aggressive phenotypes in human cancers.
Chen B; Li L; Li M; Wang X
Cell Oncol (Dordr); 2020 Oct; 43(5):877-888. PubMed ID: 32488852
[TBL] [Abstract][Full Text] [Related]
15. Cytolytic activity score as a biomarker for antitumor immunity and clinical outcome in patients with gastric cancer.
Hu Q; Nonaka K; Wakiyama H; Miyashita Y; Fujimoto Y; Jogo T; Hokonohara K; Nakanishi R; Hisamatsu Y; Ando K; Kimura Y; Masuda T; Oki E; Mimori K; Oda Y; Mori M
Cancer Med; 2021 May; 10(9):3129-3138. PubMed ID: 33769705
[TBL] [Abstract][Full Text] [Related]
16. Combined inhibition of PD-1/PD-L1, Lag-3, and Tim-3 axes augments antitumor immunity in gastric cancer-T cell coculture models.
Mimura K; Kua LF; Xiao JF; Asuncion BR; Nakayama Y; Syn N; Fazreen Z; Soong R; Kono K; Yong WP
Gastric Cancer; 2021 May; 24(3):611-623. PubMed ID: 33611641
[TBL] [Abstract][Full Text] [Related]
17. Correlate the
Lyu H; Li M; Jiang Z; Liu Z; Wang X
Comput Struct Biotechnol J; 2019; 17():1020-1030. PubMed ID: 31428295
[TBL] [Abstract][Full Text] [Related]
18. Microarray profile analysis identifies ETS1 as potential biomarker regulated by miR-23b and modulates TCF4 in gastric cancer.
Mei D; Qi Y; Xia Y; Ma J; Hu H; Ai J; Chen L; Wu N; Liao D
World J Surg Oncol; 2021 Oct; 19(1):311. PubMed ID: 34686186
[TBL] [Abstract][Full Text] [Related]
19. Cancer type-dependent correlations between TP53 mutations and antitumor immunity.
Li L; Li M; Wang X
DNA Repair (Amst); 2020 Apr; 88():102785. PubMed ID: 32007736
[TBL] [Abstract][Full Text] [Related]
20. Subtyping of head and neck squamous cell cancers based on immune signatures.
Song D; Lyu H; Feng Q; Luo J; Li L; Wang X
Int Immunopharmacol; 2021 Oct; 99():108007. PubMed ID: 34332341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
